Basic Study
Copyright ©The Author(s) 2022.
World J Gastrointest Oncol. Apr 15, 2022; 14(4): 842-857
Published online Apr 15, 2022. doi: 10.4251/wjgo.v14.i4.842
Figure 3
Figure 3 Berberine inhibited WNT5a expression in MGC803 and SGC7901 xenograft tumor models. A: Immunohistochemistry showed that berberine reduced the expression of WNT5a in tumor tissues of MGC803 and SGC7901 xenograft tumor models; B: The quantification of immunohistochemistry of the expression of WNT5a in tumor tissues of MGC803 and SGC7901 xenograft tumor models; C: The effect of berberine on WNT5a mRNA level in tumor tissues of MGC803 and SGC7901 xenograft tumor models; D: The effect of berberine on WNT5a protein expression in tumor tissues of MGC803 and SGC7901 xenograft tumor models; E: The effect of berberine on WNT5a mRNA expression in liver tissues of MGC803 and SGC7901 xenografts; F: The effect of berberine on WNT5a protein expression in liver tissues of MGC803 and SGC7901 xenografts. aP < 0.05, bP < 0.01, cP < 0.001, dP < 0.0001. Ctrl: The control group; BBR: The berberine group.